Search details
1.
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
Immunol Invest
; 52(8): 966-984, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37846958
2.
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
Int J Mol Sci
; 23(4)2022 Feb 11.
Article
in English
| MEDLINE | ID: mdl-35216137
3.
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes.
Br J Cancer
; 124(6): 1138-1149, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33402737
4.
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity.
Mol Ther
; 27(11): 1878-1891, 2019 11 06.
Article
in English
| MEDLINE | ID: mdl-31405808
5.
Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism.
Gut
; 73(3): 391-392, 2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-37898547
6.
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.
Cancer Immunol Immunother
; 68(3): 379-393, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30547218
7.
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma.
J Vasc Interv Radiol
; 30(7): 1098-1105, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31101416
8.
Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy.
J Hepatol
; 77(3): 593-595, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35714813
9.
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
J Immunol
; 195(7): 3180-9, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26324768
10.
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.
J Med Virol
; 88(5): 843-51, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26447929
11.
Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation.
Liver Int
; 35(5): 1590-6, 2015 May.
Article
in English
| MEDLINE | ID: mdl-24836705
12.
Getting insights into hepatocellular carcinoma tumour heterogeneity by multiomics dissection.
Gut
; 68(11): 1913-1914, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31375598
13.
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.
Gut
; 63(4): 665-73, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-23787026
14.
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.
J Hepatol
; 60(3): 482-9, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24418171
15.
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.
Hum Vaccin Immunother
; 20(1): 2303799, 2024 Dec 31.
Article
in English
| MEDLINE | ID: mdl-38346926
16.
Dendritic Cells in Cancer Immunology and Immunotherapy.
Cancers (Basel)
; 16(5)2024 Feb 28.
Article
in English
| MEDLINE | ID: mdl-38473341
17.
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.
J Hepatol
; 59(1): 81-8, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23466307
18.
Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.
Liver Transpl
; 19(9): 937-44, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23784747
19.
Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.
Front Immunol
; 14: 1172427, 2023.
Article
in English
| MEDLINE | ID: mdl-36936966
20.
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Nat Med
; 29(3): 632-645, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36928817